Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Entera Bio Ltd
ENTXCurrent price
0.66 USD
-0.047 USD (-6.73%)
Last closed
0.71 USD
Company
www.enterabio.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
18 884 694 USD
Yield for 12 month
+0.12 %
Week
Month
Year
ENTX
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. Its other product candidate is GLP-2, which is in preclinical trial for the treatment of short bowl syndrome; and hGh for the GH deficiency. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel. Address: Kiryat Hadassah Minrav Building, Jerusalem, Israel, 9112002
Analytics
WallStreet Target Price
10 USDP/E ratio
–Dividend Yield
–Current Year
+134 000 USD
Last Year
+571 000 USD
Current Quarter
–
Last Quarter
–
Current Year
+33 000 USD
Last Year
+198 000 USD
Current Quarter
–
Last Quarter
–
Key Figures ENTX
1 year
3 years
5 years
10 years
EBITDA
-10 394 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-54.21 %
PEG Ratio
–
Return On Equity TTM
-96.64 %
Wall Street Target Price
10 USD
Revenue TTM
14 000 USD
Book Value
0.22 USD
Revenue Per Share TTM
–
Dividend Share
–
Quarterly Revenue Growth YOY
-91.5 %
Dividend Yield
–
Gross Profit TTM
33 000 USD
Earnings Share
-0.34 USD
Diluted Eps TTM
-0.34 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ENTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ENTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ENTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
835.8331
Price Sales TTM
1348.9067
Enterprise Value EBITDA
-1.1776
Price Book MRQ
3.0283
Financials ENTX
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators ENTX
For 52 weeks
0.52 USD
1.48 USD
50 Day MA
0.69 USD
Shares Short Prior Month
54 391
200 Day MA
0.81 USD
Short Ratio
2
Shares Short
70 458
Short Percent
0.29 %
Google
Apple
Facebook